Cannabis Sell-off: Aurora Cannabis (TSX:ACB) Leads Decline in Cannabis Stocks

How long will investors hold onto Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and peer cannabis stocks? The cannabis market has failed to recover despite falling significantly in the last 12-months.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Shares of leading cannabis producer, Aurora Cannabis (TSX:ACB)(NYSE:ACB) have fallen over 17% since September 11, 2019. The stock has experienced weakness after Aurora announced its fiscal fourth quarter of 2019 (ended in June) results on September 11 after market close.

What impacted Aurora stock recently?

Aurora reported sales of $98.9 million, an impressive growth of 416% year over year. However, sales were below analyst estimates of $108.3 million as well as its own forecast. In July this year, Aurora had forecast sales between $100 million and $107 million in the June quarter.

Aurora shares were further impacted after investment firm Stifel Nicolaus downgraded the stock from “hold” to “sell.” According to one Market Watch report, Stifel Nicolaus analyst Andrew Carter provided the downgrade details in a client note. Carter stated that while Aurora missed fourth-quarter estimates, the details were far worse.

Carter expects Aurora and peer stocks to experience near-term weakness due to negative investor sentiment and regulatory issues.

The Market Watch report mentions Carter’s note, which states, “Our outlook suggests significant downside potential for the shares of Aurora over the near term, given it will be difficult for the company to continue positioning for the larger global opportunity within the confines of significant financing risk that could challenge the company’s ability to fully embrace the level of investment needed to be a leader not only in the global cannabis category but also in Canada.”

Carter and other analysts expect Aurora to experience weakness and volatility until it partners with a huge consumer product brand. Canopy Growth partnered with Constellation Brands last year. Several other cannabis stocks are growing via partnerships and investments.

Cannabis stocks have lost considerable value in the last week

After a solid start to the month, several pot stocks have declined post ACB’s earnings. The Horizons Marijuana Life Sciences Index ETF is down 5.3% since September 11. Other players, such as Hexo and Aphria, have slipped 5.9% and 9.7%, respectively, in the same period.

Pot investors have had a horrific time since marijuana was legalized last October. The investor euphoria drove several cannabis stocks to all-time highs. However, once the legalization took effect, investors were worried about high stock valuations, resulting in a market sell-off.

Pot enthusiasts are still positive about the total market opportunity for Aurora and related companies. There are, however, some regulatory issues that need to be sorted out.

Canadian provinces are not too aggressive in handing out retail licenses for cannabis stores, which could have impacted company sales.

While several analysts were optimistic about the next wave of marijuana legalization to drive cannabis stock prices higher, this has not been the case so far. Canada is poised to legalize vapes, edibles and concentrates next month. Here, too, some regulatory bodies might be concerned over the impact of vaping on young smokers.

The pot market is expected to rise at a significant rate over the next few years. The medical marijuana market in Europe, North America, and Latin America will drive this growth. Further, several countries will look to legalize recreational use as well in the coming years.

However, the cannabis market is likely to be a regulated industry for many years, potentially hindering growth prospects of marijuana producers.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »